National Institutes of Health, 55751 [2013-22051]
Download as PDF
emcdonald on DSK67QTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 176 / Wednesday, September 11, 2013 / Notices
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W412,
Bethesda, MD 20892–9750, 240–276–6374,
makridessc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Clinical Studies.
Date: November 4, 2013.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W032, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Caterina Bianco, MD,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W610, Bethesda, MD 20892–9750,
240–276–6459, biancoc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus—Drug and Gene Delivery.
Date: November 7, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Savvas C Makrides, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W412,
Bethesda, MD 20892–9750, 240–276–6374,
makridessc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Prevention Research Small Grant Program.
Date: November 20, 2013.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn RockvilleGaithersburg, 14975 Shady Grove Rd,
Rockville, MD 20850.
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W266, Bethesda, MD 20892–8329,
240–276–6385, lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Advance
Development and Validation of Emerging J2
(R33).
Date: November 20, 2013.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
4W032, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W238,
Bethesda, MD 20892–8329, 240–276–6371,
decluej@mail.nih.gov.
VerDate Mar<15>2010
16:50 Sep 10, 2013
Jkt 229001
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI—
Omnibus.
Date: November 21, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Washington, DC/
Rockville, 3 Research Court, Rockville, MD
20850.
Contact Person: Donald L Coppock, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W260,
Bethesda, MD 20892–9750, 240–276–6382,
donald.coppock@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Nanotechnology-based Theranostics.
Date: November 21, 2013.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
6W032, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Savvas C Makrides, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W412,
Bethesda, MD 20892–9750, 240–276–6374,
makridessc@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://dea
info.nci.nih.gov/advisory/irg/irg.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 5, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–22054 Filed 9–10–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be open to the
public as indicated below, with
PO 00000
Frm 00076
Fmt 4703
Sfmt 9990
55751
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: October 17, 2013.
Open: 8:30 a.m. to 2:00 p.m.
Agenda: Following opening remarks by the
Director, NEI, there will be presentations by
the staff of the Institute and discussions
concerning Institute programs.
Place: National Institutes of Health,
Neuroscience Building, Conference Room D,
6001 Executive Boulevard, Rockville, MD
20852.
Closed: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Building, Conference Room D,
6001 Executive Boulevard, Rockville, MD
20852.
Contact Person: Lore Anne Mc Nicol,
Ph.D., Director, Division of Extramural
Research, National Eye Institute, National
Institutes of Health Bethesda, MD 20892,
(301) 451–2020, mcnicoll@nei.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nei.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: September 5, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–22051 Filed 9–10–13; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\11SEN1.SGM
11SEN1
Agencies
[Federal Register Volume 78, Number 176 (Wednesday, September 11, 2013)]
[Notices]
[Page 55751]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-22051]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Eye Council.
Date: October 17, 2013.
Open: 8:30 a.m. to 2:00 p.m.
Agenda: Following opening remarks by the Director, NEI, there
will be presentations by the staff of the Institute and discussions
concerning Institute programs.
Place: National Institutes of Health, Neuroscience Building,
Conference Room D, 6001 Executive Boulevard, Rockville, MD 20852.
Closed: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Building,
Conference Room D, 6001 Executive Boulevard, Rockville, MD 20852.
Contact Person: Lore Anne Mc Nicol, Ph.D., Director, Division of
Extramural Research, National Eye Institute, National Institutes of
Health Bethesda, MD 20892, (301) 451-2020, mcnicoll@nei.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nei.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.867,
Vision Research, National Institutes of Health, HHS)
Dated: September 5, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-22051 Filed 9-10-13; 8:45 am]
BILLING CODE 4140-01-P